-
WHO to Release New Hepatitis B Guidelines, Focusing on Expanding Treatment Eligibility and Simplifying Diagnosis and Treatment Pathways
-
Dr. Linda Wong: Adjuvant Therapy Could Usher in a New Paradigm for Early-Stage Liver Cancer Treatment
-
Dr. Oi-Lin Ng: Heterogeneity of Liver Cancer and its Biological Markers
-
Dr. Hanchong Toh: Promising Prospects for Immune Adjuvant Therapy in Liver Cancer
-
Dr. Kathryn J. Fowler: When to Consider Biopsy – Radiologist’s Perspective
-
Dr. Masatoshi Kudo: Does the Treatment Paradigm for Intermediate HCC Need to Change?
-
Combined Radiotherapy, Anti-Angiogenic Medication, and Immunotherapy for Downstaging Treatment in Hepatocellular Carcinoma Complicated by Portal Vein
-
Dr. Huichuan Sun: Focusing on the Asia-Pacific Region, Leading the Frontier – Exploring Breakthroughs in the Treatment of Hepatobiliary Tumor
-
Dr. Xinwei Wang: The Molecular Landscape and Clinical Significance of Liver Cancer
-
Interview with Dr. Girard Deciphers at ELCC 2023
-
Dr. P. Garrido Lopez Interprets Latest Data from CHRYSALIS
-
Dr. Huiqiang Huang: Just around the corner! Extranodal NK/T-cell lymphoma is ushering in the era of immunotherapy.
Connecting Medical Expertise through Media